Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6215.5000 139.00 (2.29%)
NSE May 14, 2025 15:31 PM
Volume: 576.3K
 

logo
Divi's Laboratories Ltd.
29 May 2017
6215.50
2.29%
buy
by HDFC Securities
HDFC Securities
Revenue increased by 9.21% to Rs. 1063.14 Cr in Q4FY17 when compared to the previous quarter.
 
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended
Market closes higher, HAL's Q4 revenue beats Forecaster estimates by 13.5%
Trendlyne Marketwatch | 14 May 2025, 03:55PM
Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs
The Baseline | 14 May 2025, 09:48AM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022